Literature DB >> 16218472

Cardiac involvement in autoimmune myositis and mixed connective tissue disease.

I E Lundberg1.   

Abstract

The clinical cardiac manifestations most frequently reported in idiopathic inflammatory myopathies, myositis, are congestive heart failure, conduction abnormalities, that may lead to complete heart block and coronary artery disease. Although clinically overt cardiac involvement is rarely reported in myositis patients, subclinical manifestations are frequently observed and are predominated by conduction abnormalities and arrhythmias detected by ECG. Furthermore, cardiovascular manifestations constitute a major cause of death in myositis, thus cardiac involvement maybe overlooked in these patients. Also children with juvenile dermatomyositis may develop cardiac involvement although the frequency seems to be low. The underlying pathophysiologic mechanisms that may cause cardiac manifestations could involve myocarditis and coronary artery disease as well as involvement of the small vessels of the myocardium. In patients with mixed connective tissue disease (MCTD) clinically significant cardiac involvement is also rare, the most frequently reported manifestations being pericarditis and pulmonary hypertension, the latter often attributable to small vessel disease, and often a prognostic unfavourable manifestation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16218472     DOI: 10.1191/0961203305lu2205oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  16 in total

1.  Cardiac tamponade as an initial manifestation of systemic lupus erythematosus.

Authors:  Diego M Carrion; Andres F Carrion
Journal:  BMJ Case Rep       Date:  2012-06-12

2.  A case of mixed connective tissue disease complicated with hypertrophic obstructive cardiomyopathy.

Authors:  Hideki Nakamura; Seiko Tateishi; Atsushi Kawakami; Hiroaki Ida; Taku Fukuda; Michiyo Sasaki; Yuji Koide; Naoto Ashizawa; Shinji Seto; Tomayoshi Hayashi; Shinichi Sato; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2008-05-21       Impact factor: 2.631

3.  Pulmonary hypertension in polymyositis.

Authors:  Han Wang; Tao Liu; Ying-ying Cai; Lian Luo; Meng Wang; Mengmeng Yang; Lin Cai
Journal:  Clin Rheumatol       Date:  2015-10-14       Impact factor: 2.980

4.  Anti-PD1 associated fulminant myocarditis after a single pembrolizumab dose: the role of occult pre-existing autoimmunity.

Authors:  Nicolas Martinez-Calle; Paula Rodriguez-Otero; Sara Villar; Luis Mejías; Ignacio Melero; Felipe Prosper; Patricia Marinello; Bruno Paiva; Miguel Idoate; Jesus San-Miguel
Journal:  Haematologica       Date:  2018-04-12       Impact factor: 9.941

5.  Hypertension, tachycardia, and reversible cardiomyopathy temporally associated with milnacipran use.

Authors:  Mervyn B Forman; Paul G Sutej; Edwin K Jackson
Journal:  Tex Heart Inst J       Date:  2011

6.  Acute Kidney Injury Following Dermatomyositis.

Authors:  Majdi Hamadeh; Sora Boustany; Jawad Fares
Journal:  Clin Med Res       Date:  2019-07-15

Review 7.  Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis.

Authors:  Bryan Q Abadie; Paul C Cremer
Journal:  BioDrugs       Date:  2022-05-31       Impact factor: 7.744

8.  Symptomatic arrhythmia in the form of multiple premature ventricular extrasystoles as the first symptom of polymyositis.

Authors:  Małgorzata Peregud-Pogorzelska; Małgorzata Zielska; Jarosław Kaźmierczak
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-01-30       Impact factor: 1.468

9.  Trends in dermatomyositis- and polymyositis-related mortality in the state of São Paulo, Brazil, 1985-2007: multiple cause-of-death analysis.

Authors:  Augusto H Santo; José Maria P Souza; Celso E Pinheiro; Deborah Cc Souza; Emilia I Sato
Journal:  BMC Public Health       Date:  2010-10-11       Impact factor: 3.295

10.  The spectrum of renal involvement in patients with inflammatory myopathies.

Authors:  Grégoire Couvrat-Desvergnes; Agathe Masseau; Olivier Benveniste; Alexandra Bruel; Baptiste Hervier; Jean-Marie Mussini; David Buob; Eric Hachulla; Philippe Rémy; Raymond Azar; Evelyne Mac Namara; Brigitte MacGregor; Laurent Daniel; Adeline Lacraz; Thomas De Broucker; Philippe Rouvier; Philippe Carli; Maurice Laville; Etienne Dantan; Mohamed Hamidou; Anne Moreau; Fadi Fakhouri
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.